Tecan Injection 4 mg/4 ml contains Topotecan, a topoisomerase I inhibitor used in the treatment of various cancers. Topotecan interferes with the DNA replication process, preventing tumor cell proliferation and inducing apoptosis in rapidly dividing cancer cells. Tecan is primarily used for ovarian cancer, small cell lung cancer (SCLC), and cervical cancer, particularly in patients who have relapsed or are resistant to first-line chemotherapy. Administered intravenously, Tecan is suitable for hospital-based chemotherapy protocols and can be used in both single-agent and combination therapy regimens.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Uses and Benefits

• Ovarian Cancer: Effective for relapsed or platinum-resistant cases.

• Small Cell Lung Cancer (SCLC): Used in previously treated or relapsed patients.

• Cervical Cancer: Provides therapeutic benefits in recurrent or metastatic disease.

• Rapid Antitumor Activity: Inhibits topoisomerase I, causing DNA damage and apoptosis in tumor cells.

• Combination Therapy: Can be used alongside other chemotherapeutic agents to enhance efficacy.

Mechanism of Action

Topotecan binds to topoisomerase I-DNA complexes, stabilizing them and preventing the re-ligation of single-strand DNA breaks. This interferes with DNA replication and transcription, leading to DNA damage and apoptosis in rapidly dividing cancer cells.

Dosage and Administration

• Route: Intravenous infusion only.

• Concentration: 4 mg/4 ml solution for dilution prior to infusion.

• Dosage: Calculated based on body surface area and type of cancer. Typical doses range from 1.5 mg/m²/day for 5 consecutive days per treatment cycle.

• Administration: Infuse under hospital supervision; careful attention to dosing and infusion rate is essential.

• Treatment Cycle: Usually repeated every 3–4 weeks, depending on patient response and tolerance.

• Monitoring: Blood counts, liver and kidney function, and overall patient condition must be monitored regularly.

Precautions and Safety Information

• Medical History: Inform your doctor about low blood counts, liver or kidney dysfunction, infections, or previous hypersensitivity reactions.

• Pregnancy and Lactation: Contraindicated; effective contraception required during and after treatment.

• Hematologic Monitoring: Topotecan may cause severe myelosuppression; regular CBC monitoring is mandatory.

• Drug Interactions: Avoid co-administration with other myelosuppressive agents unless under strict medical supervision.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Tecan Injection may cause both common and serious side effects, including:

• Hematologic: Neutropenia, anemia, thrombocytopenia

• Gastrointestinal: Nausea, vomiting, diarrhea, mucositis

• Neurological: Fatigue, dizziness

• Infections: Increased susceptibility due to neutropenia

• Rare: Severe allergic reactions or liver toxicity

Side effects are managed with dose adjustment, supportive care, and close monitoring.

Storage

• Store vials at 2–8°C (refrigerated).

• Protect from light and freezing.

• Keep out of reach of children.

Tecan Injection 4 mg/4 ml is a potent chemotherapeutic option for treating ovarian, small cell lung, and cervical cancers. Administered under medical supervision, it effectively inhibits tumor growth and enhances patient outcomes in relapsed or resistant cancer cases.